Multicolor Scanning Laser Imaging in Diabetic Retinopathy

SIGNIFICANCEDiabetic retinopathy is a common cause of blindness in individuals younger than 60 years. Screening for retinopathy is undertaken using conventional color fundus photography and relies on the identification of hemorrhages, vascular abnormalities, exudates, and cotton-wool spots. These ca...

Full description

Saved in:
Bibliographic Details
Published inOptometry and vision science Vol. 94; no. 11; pp. 1058 - 1061
Main Authors Ahmad, Mohammad S Z, Carrim, Zia Iqbal
Format Journal Article
LanguageEnglish
Published United States American Academy of Optometry 01.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:SIGNIFICANCEDiabetic retinopathy is a common cause of blindness in individuals younger than 60 years. Screening for retinopathy is undertaken using conventional color fundus photography and relies on the identification of hemorrhages, vascular abnormalities, exudates, and cotton-wool spots. These can sometimes be difficult to identify. PURPOSEMulticolor scanning laser imaging, a new imaging modality, may have a role in improving screening outcomes, as well as facilitating treatment decisions. METHODSObservational case series comprising two patients with known diabetes who were referred for further examination after color fundus photography revealed abnormal findings. Multicolor scanning laser imaging was undertaken. Features of retinal disease from each modality were compared. RESULTSMulticolor scanning laser imaging provides superior visualization of retinal anatomy and pathology, thereby facilitating risk stratification and treatment decisions. CONCLUSIONSMulticolor scanning laser imaging is a novel imaging technique offering the potential for improving the reliability of screening for diabetic retinopathy. Validation studies are warranted.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1040-5488
1538-9235
DOI:10.1097/OPX.0000000000001128